Informação sobre produto
- 1-Naphthalenemethanamine
- a-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-
- (aR)-
- (aR)-a-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethanamine
- AMG 073
- N-[(1R)-1-(1-Naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine
- (αR)-α-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethanamine
- 1-Naphthalenemethanamine, α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-, (αR)-
- Amg 073
- Cinacalcel
- Ver mais sinónimos
- N-((1R)-1-(1-Naphthyl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine
- N-[(1R)-1-(naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine
- N-[(1R)-1-(naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride (1:1)
- Parareg
Applications Cinacalcet is the first calcimimetic drug approved by the United States Food and Drug Administration for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
References Block, G, et al.: Am. J. Kidney Dis., 35, 1226 (2000), Moe, S., et al.: Am. J. Nephrol., 23, 369 (2003), Block, G., et al.: J. Am. Soc. Nephrol., 15, 2208 (2004).
Propriedades químicas
Consulta técnica sobre: TR-C441790 Cinacalcet
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.